XML 42 R35.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Business Segment Information - Schedule of Business Segment Information (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Aug. 03, 2024
Jul. 29, 2023
Aug. 03, 2024
Jul. 29, 2023
Feb. 03, 2024
Segment Reporting Information [Line Items]          
Net sales $ 525,188 [1] $ 523,027 [2] $ 982,785 [3] $ 1,006,359 [4]  
Segment operating income (loss) (9,496) (10,000) (41,046) (32,689)  
Goodwill impairment 0 28,453 [5] 0 28,453 [6]  
Asset impairments and other 778 [7] 174 [7] 1,356 [8] 482 [9]  
Operating loss (10,274) (38,627) (42,402) (61,624)  
Other components of net periodic benefit cost 86 148 195 240  
Interest expense, net 1,345 2,383 2,235 4,034  
Loss from continuing operations before income taxes (11,705) (41,158) (44,832) (65,898)  
Total assets 1,383,751 [10] 1,494,759 [11] 1,383,751 [10] 1,494,759 [11] $ 1,329,890
Depreciation and amortization 13,169 11,833 26,406 23,119  
Capital expenditures 7,897 18,063 14,274 35,298  
Journeys Group          
Segment Reporting Information [Line Items]          
Net sales 298,846 [1] 287,275 [2] 558,291 [3] 559,465 [4]  
Schuh Group          
Segment Reporting Information [Line Items]          
Net sales 124,561 [1] 122,799 [2] 216,910 [3] 215,904 [4]  
Johnston & Murphy Group          
Segment Reporting Information [Line Items]          
Net sales 71,037 [1] 77,785 [2] 150,244 [3] 160,412 [4]  
Genesco Brands Group          
Segment Reporting Information [Line Items]          
Net sales 30,744 [1] 35,168 [2] 57,340 [3] 70,578 [4]  
Goodwill impairment   28,500   28,500  
Operating Segments          
Segment Reporting Information [Line Items]          
Net sales 525,199 523,323 980,799 1,007,112  
Operating Segments | Journeys Group          
Segment Reporting Information [Line Items]          
Net sales 298,846 287,275 558,291 559,465  
Segment operating income (loss) (11,151) (14,878) (29,973) (33,240)  
Goodwill impairment   0 [5]   0 [6]  
Asset impairments and other 0 [7] 0 [12] 0 [8] 0 [9]  
Operating loss (11,151) (14,878) (29,973) (33,240)  
Other components of net periodic benefit cost 0 0 0 0  
Interest expense, net 0 0 0 0  
Loss from continuing operations before income taxes (11,151) (14,878) (29,973) (33,240)  
Total assets 668,528 [10] 769,844 [11] 668,528 [10] 769,844 [11]  
Depreciation and amortization 8,540 7,810 17,160 15,157  
Capital expenditures 4,313 11,193 7,804 24,212  
Operating Segments | Schuh Group          
Segment Reporting Information [Line Items]          
Net sales 124,561 122,799 216,910 215,904  
Segment operating income (loss) 7,339 8,416 1,443 6,626  
Goodwill impairment   0 [5]   0 [6]  
Asset impairments and other 0 [7] 0 [7] 0 [8] 0 [9]  
Operating loss 7,339 8,416 1,443 6,626  
Other components of net periodic benefit cost 0 0 0 0  
Interest expense, net 0 0 0 0  
Loss from continuing operations before income taxes 7,339 8,416 1,443 6,626  
Total assets 205,488 [10] 218,913 [11] 205,488 [10] 218,913 [11]  
Depreciation and amortization 1,849 1,624 3,718 3,185  
Capital expenditures 1,764 3,845 2,497 5,996  
Operating Segments | Johnston & Murphy Group          
Segment Reporting Information [Line Items]          
Net sales 71,037 77,788 150,244 160,418  
Segment operating income (loss) (403) 2,666 1,952 7,472  
Goodwill impairment   0 [5]   0 [6]  
Asset impairments and other 0 [7] 0 [7] 0 [8] 0 [9]  
Operating loss (403) 2,666 1,952 7,472  
Other components of net periodic benefit cost 0 0 0 0  
Interest expense, net 0 0 0 0  
Loss from continuing operations before income taxes (403) 2,666 1,952 7,472  
Total assets 157,936 [10] 187,379 [11] 157,936 [10] 187,379 [11]  
Depreciation and amortization 1,394 1,137 2,778 2,257  
Capital expenditures 1,461 2,097 3,176 3,302  
Operating Segments | Genesco Brands Group          
Segment Reporting Information [Line Items]          
Net sales 30,755 35,461 55,354 71,325  
Segment operating income (loss) 2,672 1,851 1,686 1,819  
Goodwill impairment   0 [5]   0 [6]  
Asset impairments and other 0 [7] 0 [7] 0 [8] 0 [9]  
Operating loss 2,672 1,851 1,686 1,819  
Other components of net periodic benefit cost 0 0 0 0  
Interest expense, net 0 0 0 0  
Loss from continuing operations before income taxes 2,672 1,851 1,686 1,819  
Total assets 80,954 [10] 56,977 [11] 80,954 [10] 56,977 [11]  
Depreciation and amortization 331 201 645 404  
Capital expenditures 304 623 535 1,078  
Corporate & Other          
Segment Reporting Information [Line Items]          
Net sales 0 [1] 0 [2] 0 [3],[13] 0 [4]  
Segment operating income (loss) (7,953) (8,055) (16,154) (15,366)  
Goodwill impairment   28,453 [5]   28,453 [6]  
Asset impairments and other 778 [7] 174 [7] 1,356 [8] 482 [9]  
Operating loss (8,731) (36,682) (17,510) (44,301)  
Other components of net periodic benefit cost 86 148 195 240  
Interest expense, net 1,345 2,383 2,235 4,034  
Loss from continuing operations before income taxes (10,162) (39,213) (19,940) (48,575)  
Total assets 270,845 [10] 261,646 [11] 270,845 [10] 261,646 [11]  
Depreciation and amortization 1,055 1,061 2,105 2,116  
Capital expenditures 55 305 262 710  
Intercompany Sales Elimination          
Segment Reporting Information [Line Items]          
Net sales (11) (296) 1,986 [13] (753)  
Intercompany Sales Elimination | Journeys Group          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 [13] 0  
Intercompany Sales Elimination | Schuh Group          
Segment Reporting Information [Line Items]          
Net sales 0 0 0 [13] 0  
Intercompany Sales Elimination | Johnston & Murphy Group          
Segment Reporting Information [Line Items]          
Net sales 0 (3) 0 [13] (6)  
Intercompany Sales Elimination | Genesco Brands Group          
Segment Reporting Information [Line Items]          
Net sales $ (11) $ (293) $ 1,986 [13] $ (747)  
[1] Net sales in North America and in the U.K., which includes the ROI, accounted for 76% and 24%, respectively, of our net sales in the second quarter of Fiscal 2025
[2] Net sales in North America and in the U.K., which includes the ROI, accounted for 77% and 23%, respectively, of our net sales for the second quarter of Fiscal 2024.
[3] Net sales in North America and in the U.K., which includes the ROI, accounted for 78% and 22%, respectively, of our net sales in the first six months of Fiscal 2025.
[4] Net sales in North America and in the U.K., which includes the ROI, accounted for 79% and 21%, respectively, of our net sales for the first six months of Fiscal 2024.
[5] Goodwill impairment of $28.5 million is related to Genesco Brand Group.
[6] Goodwill impairment of $28.5 million is related to Genesco Brand Group.
[7] Asset impairments and other includes a $0.1 million charge for asset impairments in Journeys Group and $0.7 million for severance.
[8] Asset impairments and other includes a $0.4 million charge for asset impairments in Journeys Group and $1.0 million for severance.
[9] Asset impairments and other includes a $0.5 million charge for asset impairments in Journeys Group.
[10] Of our $631.8 million of long-lived assets, $92.1 million and $11.0 million relate to long-lived assets in the U.K. and Canada, respectively.
[11] Of our $720.8 million of long-lived assets, $94.4 million and $14.7 million relate to long-lived assets in the U.K. and Canada, respectively.
[12] Asset impairments and other includes a $0.2 million charge for asset impairments in Journeys Group
[13] Intercompany sales for the first six months of Fiscal 2025 reflect net intercompany returns.